Associations between the activity of placental nutrient-sensing pathways and neonatal and postnatal metabolic health: the ECHO Healthy Start cohort

Abstract

Objective Our hypothesis was that the activity of placental nutrient-sensing pathways is associated with adiposity and metabolic health in childhood. Research design and methods Using placental villus samples from healthy mothers from the Healthy Start Study, we measured the abundance and phosphorylation of key intermediates in the mTOR, insulin, AMPK, and ER stress signaling pathways. Using multivariate multiple regression models, we tested the association between placental proteins and offspring adiposity (%fat mass) at birth (n = 109), 4-6 months (n = 104), and 4-6 years old (n = 64), adjusted for offspring sex and age. Results Placental mTORC1 phosphorylation was positively associated with adiposity at birth (R-2 = 0.13, P = 0.009) and 4-6 years (R-2 = 0.15, P = 0.046). The mTORC2 target PKC alpha was positively associated with systolic blood pressure at 4-6 years (beta = 2.90, P = 0.005). AMPK phosphorylation was positively associated with adiposity at birth (beta = 2.32, P = 0.023), but the ratio of phosphorylated to total AMPK was negatively associated with skinfold thickness (beta = -2.37, P = 0.022) and body weight (beta = -2.92, P = 0.005) at 4-6 years. Conclusions This is the first report of associations between key placental protein activity measures and longitudinal child outcomes at various life stages. Our data indicate that AMPK and mTOR signaling are linked to cardiometabolic measures at birth and 4-6 years, providing novel insight into potential mechanisms underpinning how metabolic signaling in the placenta is associated with future risk of cardiovascular disease.